- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1699-3055
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Pediatric medulloblastoma express immune checkpoint B7-H3 ; day:5 ; month:1 ; year:2022 ; pages:1-5
Clinical and translational oncology ; (5.1.2022), 1-5
- Urheber
-
Li, S.
Poolen, G. C.
Vliet, L. C. van
Schipper, J. G.
Broekhuizen, R.
Monnikhof, M.
Hecke, W. Van
Vermeulen, J. F.
Bovenschen, N.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s12094-021-02762-y
- URN
-
urn:nbn:de:101:1-2022042301223506152035
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:36 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Li, S.
- Poolen, G. C.
- Vliet, L. C. van
- Schipper, J. G.
- Broekhuizen, R.
- Monnikhof, M.
- Hecke, W. Van
- Vermeulen, J. F.
- Bovenschen, N.
- SpringerLink (Online service)
Ähnliche Objekte (12)
New frontiers in immune checkpoint B7-H3 (CD276) research and drug development
Immune checkpoint B7-H3 is a potential therapeutic target in prostate cancer
Immune checkpoint of B7-H3 in cancer: from immunology to clinical immunotherapy
Identification of the receptor B7-H3
Mifepristone inhibited the expression of B7-H2, B7-H3, B7-H4 and PD-L2 in adenomyosis
ITC-6102RO, a novel B7-H3 antibody-drug conjugate, exhibits potent therapeutic effects against B7-H3 expressing solid tumors
Correction: Mifepristone inhibited the expression of B7-H2, B7-H3, B7-H4 and PD-L2 in adenomyosis
A promising target for breast cancer: B7-H3
B7-H3 is widely expressed in soft tissue sarcomas
The prognostic impact of B7-H3 and B7-H4 in head and neck squamous cell carcinoma
Clinical significance and correlation of PD-L1, B7-H3, B7-H4, and TILs in pancreatic cancer
The prognostic impact of B7-H3 and B7-H4 in head and neck squamous cell carcinoma
New frontiers in immune checkpoint B7-H3 (CD276) research and drug development
Immune checkpoint B7-H3 is a potential therapeutic target in prostate cancer
Immune checkpoint of B7-H3 in cancer: from immunology to clinical immunotherapy
Identification of the receptor B7-H3
Mifepristone inhibited the expression of B7-H2, B7-H3, B7-H4 and PD-L2 in adenomyosis
ITC-6102RO, a novel B7-H3 antibody-drug conjugate, exhibits potent therapeutic effects against B7-H3 expressing solid tumors
Correction: Mifepristone inhibited the expression of B7-H2, B7-H3, B7-H4 and PD-L2 in adenomyosis
A promising target for breast cancer: B7-H3
B7-H3 is widely expressed in soft tissue sarcomas
The prognostic impact of B7-H3 and B7-H4 in head and neck squamous cell carcinoma
Clinical significance and correlation of PD-L1, B7-H3, B7-H4, and TILs in pancreatic cancer
The prognostic impact of B7-H3 and B7-H4 in head and neck squamous cell carcinoma
New frontiers in immune checkpoint B7-H3 (CD276) research and drug development
Immune checkpoint B7-H3 is a potential therapeutic target in prostate cancer
Immune checkpoint of B7-H3 in cancer: from immunology to clinical immunotherapy
Identification of the receptor B7-H3
Mifepristone inhibited the expression of B7-H2, B7-H3, B7-H4 and PD-L2 in adenomyosis
ITC-6102RO, a novel B7-H3 antibody-drug conjugate, exhibits potent therapeutic effects against B7-H3 expressing solid tumors
Correction: Mifepristone inhibited the expression of B7-H2, B7-H3, B7-H4 and PD-L2 in adenomyosis
A promising target for breast cancer: B7-H3
B7-H3 is widely expressed in soft tissue sarcomas
The prognostic impact of B7-H3 and B7-H4 in head and neck squamous cell carcinoma
Clinical significance and correlation of PD-L1, B7-H3, B7-H4, and TILs in pancreatic cancer